Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Adverse Events”

390 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 390 results

Not applicableStudy completedNCT07259837
What this trial is testing

Association Between Preoperative Health and Functional Status and Postoperative Complications in Elderly Patients

Who this might be right for
Functional StatusPostoperative ComplicationsOlder Adults (65 Years and Older)
Chinese PLA General Hospital 8,751
Not applicableLooking for participantsNCT06763081
What this trial is testing

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

Who this might be right for
Behavioral ActivationMajor Depressive DisorderAnxiety Disorders+3 more
University of Manitoba 160
Not applicableStudy completedNCT00901030
What this trial is testing

Association Between Perioperative Platelet Function and Major Adverse Perioperative Events

Who this might be right for
Surgery
Hamilton Health Sciences Corporation 250
Testing effectiveness (Phase 2)Ended earlyNCT05044234
What this trial is testing

Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
AbbVie 156
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Not applicableStudy completedNCT02099565
What this trial is testing

Observational Prospective Study OPTIMA II - Follow-up

Who this might be right for
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
AstraZeneca 572
Post-approval studies (Phase 4)UnknownNCT03882775
What this trial is testing

Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction

Who this might be right for
STEMIPercutaneous Coronary InterventionAged
The First Affiliated Hospital of Dalian Medical University 240
Post-approval studies (Phase 4)Looking for participantsNCT06909565
What this trial is testing

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Who this might be right for
Percutaneous Coronary InterventionPeripheral Endovascular Intervention
Duke University 6,000
Not applicableUnknownNCT05562089
What this trial is testing

Prevail Drug Balloon Study

Who this might be right for
Myocardial InfarctionDrug-Coated Balloon
Chinese University of Hong Kong 50
Not applicableLooking for participantsNCT06406998
What this trial is testing

Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD

Who this might be right for
Cardiovascular DiseasesAtherosclerosisPregnancy Complications+2 more
Samsung Medical Center 5,461,222
Not applicableUnknownNCT03640884
What this trial is testing

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

Who this might be right for
Adverse Drug EventAdverse Drug ReactionsAnaphylactic Reaction+1 more
Zhong Wang 30,000
Not applicableStudy completedNCT04095143
What this trial is testing

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury

Who this might be right for
Acute Kidney InjuryFluid OverloadUltrasonography
Centre hospitalier de l'Université de Montréal (CHUM) 125
Large-scale testing (Phase 3)Ended earlyNCT00107081
What this trial is testing

Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Who this might be right for
FeverNeutropeniaCancer
Swiss Pediatric Oncology Group 70
Post-approval studies (Phase 4)Study completedNCT01431495
What this trial is testing

Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)

Who this might be right for
Coronary Disease
Les Laboratoires des Médicaments Stériles 219
Not applicableActive Not RecruitingNCT03436238
What this trial is testing

Myocardial Injury in Noncardiac Surgery in Sweden

Who this might be right for
Perioperative/Postoperative ComplicationsRisk Factor, Cardiovascular
Linkoeping University 1,269
Large-scale testing (Phase 3)Looking for participantsNCT06461897
What this trial is testing

Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 675
Testing effectiveness (Phase 2)Study completedNCT05570006
What this trial is testing

Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 30
Not applicableLooking for participantsNCT07374263
What this trial is testing

Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

Who this might be right for
Acquired Long QTVentricular ArrhythmiasTorsades de Pointes+3 more
St. Joseph's Healthcare Hamilton 990,000
Not applicableUnknownNCT06318767
What this trial is testing

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Who this might be right for
Major Adverse Limb EventsMajor Adverse Cardiovascular EventsPeripheral Artery Disease+2 more
Centre Hospitalier Universitaire, Amiens 134
Large-scale testing (Phase 3)Active Not RecruitingNCT06063967
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

Who this might be right for
Crohn's Disease
AbbVie 289
Load More Results